Vascular Endothelial Growth Factor Levels in Patients Undergoing Embryo Transfer
NCT ID: NCT04261660
Last Updated: 2020-02-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
90 participants
OBSERVATIONAL
2020-03-01
2021-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prothrombotic Biomarkers and Ovarian Stimulation
NCT04188444
Maternal Serum Cytokine Levels and Angiogenic Factor Levels in IVF vs Spontaneously Conceived Pregnancies
NCT00837278
Assessment of Some Metabolic and Hematological Markers in Women Exposed to in Vitro Fertilization
NCT06812663
The Role of hCG in Thawed Embryo Transfer
NCT07004192
Cleavage-stage Versus Blastocyst-stage Embryo Transfer in IVF Patients With Few Embryos
NCT06746129
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
fresh
NO INTERVENTION
NO intervention
NO INTERVENTION
Frozen embro transfer natural
NO INTERVENTION
NO intervention
NO INTERVENTION
Frozen embro transfer hormonal
NO INTERVENTION
NO intervention
NO INTERVENTION
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NO intervention
NO INTERVENTION
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients request to be withdrawn
18 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Carmel Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ido Feferkorn
Physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ido Feferkorn, MD
Role: PRINCIPAL_INVESTIGATOR
Carmel Medical Center
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CMC-19-0161-CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.